Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02271919 · ClinicalTrials.gov registry record · Phase 4
Varenicline and Combined NRT for Smoking Cessation
A Phase 4 study of Tobacco Use Disorder and Cigarette Smoker, sponsored by M.D. Anderson Cancer Center.
- Active
- Registry status
- Phase 4
- Development phase
- 631
- Enrollment target
- 1
- Study location
NCT02271919 is a Phase 4 study of Tobacco Use Disorder and Cigarette Smoker that is active but no longer recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 631 participants, above the 230-participant average among 70 other Tobacco Use Disorder trials with a reported enrollment target (174% higher). The trial reports 1 study location across 1 state.
The verdict
NCT02271919, a Phase 4 study of Tobacco Use Disorder and Cigarette Smoker, is active but no longer recruiting, sponsored by M.D. Anderson Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 4
- Development phase
- 631 participants
- Enrollment target
- 1
- Study location
Study Summary
This randomized pilot phase IV trial studies the side effects and how well varenicline works compared to nicotine replacement therapy in helping patients that smoke to quit. Varenicline is a drug that acts the same way as nicotine in the brain but is not habit-forming. Nicotine replacement therapy consists of nicotine patches and lozenges. It is not yet known if varenicline is more effective than nicotine replacement therapy in helping patients quit smoking.
Conditions Studied
Interventions
- OTHER Placebo
- DRUG Varenicline
- OTHER Tobacco Cessation Counseling
- DRUG Nicotine Patch
- DRUG Nicotine Lozenge
Study Locations (1)
Texas
- M D Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 631 participants |
| Start Date | 2015-05-14 |
| Est. Completion | 2026-06-30 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02271919
The ClinicalTrials.gov registry entry for NCT02271919 describes a study currently listed as active not recruiting, categorized as Phase 4. The registered enrollment target is 631 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 230-participant average among 70 other Tobacco Use Disorder trials with a reported enrollment target (174% higher). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Tobacco Use Disorder appearing as the primary indexed condition, and to 5 interventions - of which Placebo is the first listed.
NCT02271919 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT02271919 about?
NCT02271919 is a clinical study titled "Varenicline and Combined NRT for Smoking Cessation". This randomized pilot phase IV trial studies the side effects and how well varenicline works compared to nicotine replacement therapy in helping patients that smoke to quit. Varenicline is a drug that acts the same way as nicotine in the brain but is not habit-forming. Nicotine replacement therapy c...
What is the current status of trial NCT02271919?
This trial is currently active not recruiting. It is a Phase 4 study. The enrollment target is 631 participants. The study started on 2015-05-14. Estimated completion is 2026-06-30.
What conditions does trial NCT02271919 study?
This clinical trial studies the following conditions: Tobacco Use Disorder, Cigarette Smoker.
What interventions are being tested in trial NCT02271919?
The interventions under investigation include: Placebo (OTHER), Varenicline (DRUG), Tobacco Cessation Counseling (OTHER), Nicotine Patch (DRUG), Nicotine Lozenge (DRUG).
Who is sponsoring clinical trial NCT02271919?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02271919 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tobacco Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Beta-Adrenergic Modulation of Drug Cue Reactivity
RECRUITING · Phase 4
-
E-cigarette Cessation in Adults Who Co-use Cannabis
RECRUITING · Phase 4
-
Smokers' Health Project: Self-Determination and Maintaining Tobacco Abstinence
COMPLETED · Phase 4
-
A Comparison of Bupropion SR and Placebo for Smoking Cessation
COMPLETED · Phase 4
-
Varenicline Effects In Schizophrenic Smokers
COMPLETED · Phase 4
-
Nicotine Regulation for Dual Users of E-cigarettes and Cigarettes
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.